Evidence map›Paper›PMID 38543254›Full record

ArticlePharmaceutics2024

New MoS

Miguel T Campos, Filipa A L S Silva, José Ramiro Fernandes, Susana G Santos, Fernão D Magalhães, Maria J Oliveira, Artur M Pinto

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Advances in MoSBiosensors · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Miguel T CamposLEPABE, Faculdade de Engenharia, Universidade do Porto, 4200-465 Porto, Portugal.
Filipa A L S SilvaLEPABE, Faculdade de Engenharia, Universidade do Porto, 4200-465 Porto, Portugal.
José Ramiro FernandesCQVR-Centro de Química Vila Real, University of Trás-os-Montes and Alto Douro, 5000-801 Vila Real, Portugal.ORCID 0000-0002-3300-2606
Susana G Santosi3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.
Fernão D MagalhãesLEPABE, Faculdade de Engenharia, Universidade do Porto, 4200-465 Porto, Portugal.ORCID 0000-0002-4447-4473
Maria J Oliveirai3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.
Artur M PintoLEPABE, Faculdade de Engenharia, Universidade do Porto, 4200-465 Porto, Portugal.ORCID 0000-0001-8184-8254
Universidade do Porto · PTUniversity of Trás-os-Montes and Alto Douro · PT

Funding

European Union NORTE-01-0145-FEDER-000054Fundação para a Ciência e Tecnologia 2021.05897.BDFundação para a Ciência e Tecnologia CEECIND/03908/2017 (DOI: https://doi.org/10.54499/CEECIND/03908/2017/CP1399/CT0008)Fundação para a Ciência e Tecnologia EXPL/NPN/0044/2021 - 2D-Therapy (DOI: http://doi.org/10.54499/UTAP-EXPL/NPN/0044/2021), also under the FCT project 2022.04494.PTDC - PhotoRectFundação para a Ciência e Tecnologia LA/P/0045/2020 (DOI: 10.54499/LA/P/0045/2020)Fundação para a Ciência e Tecnologia UIDB/00511/2020 (DOI: 10.54499/UIDB/00511/2020) and UIDP/00511/2020 (DOI:10.54499/UIDP/00511/2020)Fundação para a Ciência e Tecnologia UIDB/04293/2020
6 · The paper itself

Abstract

Non-melanoma skin cancer (NMSC) is one of the most common types of cancer worldwide. Despite the low mortality rate, rising incidence and recurrence rates are a burden on healthcare systems. Standard treatments such as chemotherapy, radiotherapy, and surgery are either invasive or toxic to healthy tissues; therefore, new, alternative, selective treatments are needed. In this work, a combined photothermal and chemotherapeutic approach is proposed. MoS

Indexed as

2D nanomaterialsanticancer drugsbiocompatibilityphotothermal therapytargeted selective therapyTMDCs)transition metal dichalcogenides (TMDs

Identifiers

PMID38543254
PMCPMC10974967
OpenAlexW4392380656

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.